Sanofi Recalls Auvi-Q Epinephrine Auto-Injectors Due to Defective Delivery System
Sanofi-Aventis is recalling 159,000 Auvi-Q epinephrine auto-injectors nationwide because a defective delivery system may result in inaccurate dosage delivery.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA has classified this recall as Class I, which meets the rubric criteria for a Critical severity score (5) due to the potential for serious adverse health consequences.
Plain-English summary
Sanofi-Aventis U.S. LLC is recalling 159,000 prefilled Auvi-Q (epinephrine injection, USP) Auto-Injectors, 0.15 mg, distributed nationwide. The recall involves specific lot numbers and expiration dates ranging from October 2015 to December 2016, as detailed in the agency's structured product information.
The recall was initiated because the product has a defective delivery system that poses a potential risk of inaccurate dosage delivery. This defect could affect the amount of epinephrine administered to the patient.
Consumers who have these specific products should stop using them and contact their healthcare provider or pharmacist for guidance on obtaining a replacement or alternative treatment. The FDA has classified this recall as Class I, indicating a reasonable probability that use of the product will cause serious adverse health consequences or death.
The recalled product
- Product
- Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Category
- Drug — Epinephrine Auto-Injector
- Affected units
- 159,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- a) 2144144
- exp 10/2015
- 2469674
- exp 04/2016
- 2506492
- 2546978
- 2546979
- exp 05/2016
- 2654817
- 2654818
- exp 06/2016
- 2692143
- 2692144
- exp 07/2016
- 2719838
- exp 08/2016
- 2824845
- 2891021
- 2857530
- exp 09/2016
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Sanofi-Aventis U.S. LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Sanofi-Aventis U.S. LLC
See all →- HighADMELOG Insulin Lispro Recalled for Malformed Seal Defect
FDA (Drugs) · 2023-05-24
- ModerateSanofi Recalls Elitek (Rasburicase) Vials Due to Stability Testing Failures
FDA (Drugs) · 2020-08-26
- SevereSanofi Recalls Zantac Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-12-11
- SevereSanofi Recalls Regular Strength Zantac 75 mg Due to NDMA Impurity
FDA (Drugs) · 2019-12-11
- SevereSanofi Recalls Zantac 150 mg Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-12-11
Same hazard · inaccurate dosage
See all →- HighICU Medical Recalls IV Administration Sets with Incorrect Drop Cannula
FDA (Devices) · 2020-05-13
- HighINOmax DSIR Plus Delivery System Recalled for Inaccurate Valve Calibration
FDA (Devices) · 2017-02-01
- SevereSanofi Recalls Auvi-Q Epinephrine Auto-Injectors Due to Defective Delivery System
FDA (Drugs) · 2016-06-01